The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre‐ and post‐capillary pulmonary hypertension
Author:
Affiliation:
1. Division of Cardiovascular MedicineVanderbilt University Medical CenterNashvilleTNUSA
2. Division of AllergyPulmonary, and Critical Care MedicineVanderbilt University Medical CenterNashvilleTNUSA
Funder
American Heart Association
National Center for Advancing Translational Sciences
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045893217745019
Reference33 articles.
1. Updated clinical classification of pulmonary hypertension;Simonneau G;J Am Coll Cardiol,2013
2. Pulmonary hypertension due to left heart diseases;Vachiery JL;J Am Coll Cardiol,2013
3. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure;Ghio S;J Am Coll Cardiol,2001
4. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension;Galiè N;Eur Heart J,2016
5. Diastolic pulmonary vascular pressure gradient: A predictor of prognosis in “out‐of‐proportion” pulmonary hypertension;Gerges C;Chest,2013
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction;Circulation;2024-09-10
2. Pulmonary hypertension associated to left heart disease: Phenotypes and treatment;European Journal of Internal Medicine;2024-08
3. Novel insights into the pathobiology of pulmonary hypertension in heart failure with preserved ejection fraction;American Journal of Physiology-Heart and Circulatory Physiology;2024-06-01
4. Myeloid Cell Derived IL1β Contributes to Pulmonary Hypertension in HFpEF;Circulation Research;2023-11-10
5. The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets;Vascular Pharmacology;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3